GeLongHui on October 28thཨTibet Weixinkang Pharmaceutical (603676.SH) released its third quarter report, with revenue of 0.994 billion yuan in the first three quarters, a 6.30% year-on-year decrease, a net income of 0.243 billion yuan, a 15.71% year-on-year increase, a non-GAAP net profit of 0.197 billion yuan, a 15.84% year-on-year increase, and basic earnings per share of 0.56 yuan.
卫信康(603676.SH)：前三季净利润2.43亿元 同比增长15.71%
tibet weixinkang pharmaceutical (603676.SH): The net income for the first three quarters was 0.243 billion yuan, a year-on-year increase of 15.71%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated